Haley John R
Known title: DirectorCIK: 0001526957
Haley John R's purchase track record
How the stock did after each of Haley John R's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
Purchases measured
3
of 3 since February 27, 2025
Stock higher 6 months later
67%
3 months: 67%
Median 6-month return
+2.9%
3 months: +0.1%
Beat the S&P 500
33%
median -8.1% vs. index
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 10/28/2025 | SON | $100K | +21.5% | +27.1% | +3.6% |
| 5/2/2025 | SON | $100K | +0.1% | -7.1% | +20.3% |
| 2/27/2025 | SON | $140K | -0.8% | +2.9% | +10.9% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| SON | ▲ Buy | Open Market | 2,506 | $100K | 10/28/2025 | View on chart |
| SON | ▲ Buy | Open Market | 2,246 | $100K | 5/2/2025 | View on chart |
| SON | ▲ Buy | Open Market | 3,000 | $140K | 2/27/2025 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
UBS cuts Sonoco price target to $51, maintains Neutral rating
UBS has lowered its price target for Sonoco Products to $51 while keeping a Neutral rating. This move places the bank's estimate at the bottom of the current analyst range, which spans from $51 to $70. The stock is currently trading near its support level, reflecting the cautious outlook among some analysts.
UBS cuts Sonoco price target to $51, maintains Neutral rating. UBS has lowered its price target for Sonoco Products to $51 while keeping a Neutral rating. This move places the bank's estimate at the bottom of the current analyst range, which spans from $51 to $70. The stock is currently trading near its support level, reflecting the cautious outlook among some analysts.